Status Epilepticus: Evaluation and Management

Presentation for the Pediatric Acute Care Symposium
Division of Pediatric Neurology
Department of Pediatrics
Emory University School of Medicine

Terms: Seizures and Status Epilepticus

A seizure is paroxysmal disturbance of brain electrical activity. Its onset may be focal or generalized. Focal-onset seizures may or may not become generalized. A clinical seizure is abnormal brain electrical activity that occurs in time locked association with abnormal clinical behavior change. Clinical behavior change can be motor or sensory activity.

Status Epilepticus-Definitions

Status Epilepticus is a Medical Emergency

The practical definition for Status Epilepticus is: seizures lasting longer than 10 minutes, or seizures on presentation to the Emergency Room, or seizures recurring in the ER. Remember basics of Seizure First Aid.

Types of Status Epilepticus

  1. Generalized
    • Tonic Clonic Status- One focus of this presentation
    • Absence Status
  2. Focal Status
    • Epilepsia Partialis Continua
    • Complex Partial Status
  3. Refractory Status Epilepticus - Another focus of this presentation
    • Defined as status epilepticus lasting longer than 60 minutes despite adequate doses of a benzodiazepine and a second antiepileptic (AED) drug.
    • 9-31% of all status

Incidence of Status Epilepticus


Status Epilepticus and Epilepsy

Epilepsy is a number of different chronic conditions with recurring episodes of seizures.

Outcome and Etiology are closely linked. Status has much less morbidity in children, except with progressive CNS disease.


Etiology of Status Children Mortality Adults Mortality
Fever (non-CNS infection)
36%
2%
<5%
45%
Idiopathic (afebrile)
24-39%
-
24-38%
-
Chronic neurologic disease
15%
-
10%
-
Metabolic/Toxic
8%
5%
9%
40%
Medication Change
20%
-
19%
8%
Anoxia
5%
8%
11%
65%
CNS infection
5%
-
2%
38%
Tumor
1%
36%
4%
20%
Acute Trauma/Abuse
4%
-
5%
22%
Degenerative Disease
2
-
2
-
Vascular Disease
3%
5%
25%
10%
Compiled from DeLorenzo et. al., Status epilepticus in children, adults, and the elderly.
Epilepsia 1992; 33 (suppl 4): S15-S25.

Causes of Status Epilepticus in Children

Idiopathic30%
Fever25%
Acute Symptomatic35%
Remote Symptomaic15%
Progressive5%
Shinnar (1992)

Physiologic Changes with Status, (Meldrum, 1983)


Outcome of Status Epilepticus

The most important determinants of outcome for status epilepticus are:

Outcome of Status over the Decades

Currently, status epilepticus has 1/5 the morbidity and 1/3 the mortality of pre-1970. Still, morbidity for status in children is at least 3% and as high as 30% in children with refractory status (Sahin et. al., 2001) and 30% in adults. Improvements reflect study referral bias, use of retrospective data, and changes in definitions of status (from greater than 60 minutes to much shorter duration of seizures). The most important factor for improved outcomes is improved care.

Outcome is determined by etiology, age, duration and treatment. You can affect only treatment.

Treatment and Evaluation of Status Epilepticus

Treatment and evaluation begin when the operational diagnosis is made. Treatment and evaluation are performed in parallel time-lines: do not defer treatment until test results return.

Treatment protocols (predetermined therapeutic interventions) are more likely to succeed than impromptu measures.

The goal of treatment is the cessation of both clinical and electrical seizures.

Evaluation and Treatment of Status Epilepticus

Suggested time line for the evaluation and treatment of Status Epilepticus.

Time
Evaluation
Procedure
0 min

Observe, verify, and describe seizure
VS, pulse oximetry, Dextrostx
EKG/HR monitor, Glucose, Lytes, CBC
AED levels, CRP, ABG
NH3, Tox screen
Airway, O2
Start IV
(Benzodiazepine dose #1
if seizure present on arrival)
3 to 5 min
Labs and oservation
IV fluids, glucose
Benzodiazepine dose #1
(Benzodiazepine dose #2
if seizure present on arrival)
by 10 min
Labs and oservation
Benzodiazepine dose #2
(Lorazepam or Diazepam)
AED # 1
Phenytoin 20 mg / kg IV
Phenobarbital 20 mg / kg IV
Fosphenytoin 20 mg PE/ kg IV
30-40 min
Blood Cultures, ABG
AED # 2
Phenytoin, Phenobarbital or Fosphenytoin
20 mg / kg IV
Intubation
? Antiobiotics
50-60 min
?CT, ?LP
Admit to ICU
Airway control
Circulatory, fluid and metabolic support
Seizure longer than 60 min
EEG Monitoring
    Pharmacologic Coma
  • Benzodiazepine-midazolam
  • Pentobarbitol
  • Propofol
  • Pharmacologic Coma for Refractory Status Epilepticus

    Drug Loading Dose Maintenance Dose Comments
    pentobarbital
    (Children)
    15 mg/kg iv over 1 hour
    5 mg/kg q 20 minutes
    0.5 - 1.0 mg/kg/hr
    after 12 - 24 hrs seizure free
    Decrease dose by 50%
    pentobarbital
    (Adults)
    5-12 mg/kg iv over 1 hour
    5 mg/kg q 20 minutes
    1 - 10 mg/kg/hr titrated to burst suppression
    after 12 - 24 hrs seizure free
    Decrease dose by 50%
    (Bleck,1999)
    midazolam
    (Children)
    150 - 200 µg/kg iv
    1 - 10 µg/kg/minute
    mean drip rate 2.3 µg/kg/minute
    (Rivera et al., 1993)
    midazolam
    (Adults)
    0.2 mg/kg iv
    0.1 - 0.2 mg/kg/hr
    mean drip rate 2.3 µg/kg/minute
    (Kumar and Bleck,1992)
    propofol
    (Adults)
    3-5 mg/kg iv
    1 - 15 mg/kg/hr titrated to burst suppression
    (Stecker, et. al., 1998)
    Rapid infusion may induce withdrawal "seizures"
    (Finley, et. al. 1993) (Walder et.al., 2002)

    Status Epilepticus Evaluation - Treatment Reminders


    Status Epilepticus Summary

    Status epilepticus is a common and serious condition. Children are more Susceptible to the occurrence of status, but more resistant to injury. Normal children and children with febrile status have a favorable prognosis. In all respects, children with prior, new or progressive CNS injury are more prone to have refractory status epilepticus. As a group they have higher morbidity and mortality, including later epilepsy, recurrent status, and the need for prolonged anti-epileptic drug therapy.

    Improved outcome is a result of timely and appropriate evaluation and treatment.

    References

    Available on line at www.pediatrics.emory.edu/NEURO/status.htm

    Credits

    This presentation was originated by Dr. James F. Schwartz and has evolved and been udated by Drs. Olson, Holt and others in the Division of Child Neurology.
    Return to: Emory University || Emory Pediatrics || Emory Pediatric Neurology
    Pediatric Neurology: Clinical Programs || Training Programs || Research || Syllabus Contents
    Epilepsy Foundation Georgia at 404-527-7155 or www.epilepsyga.org.
    Epilepsy Foundation of America by calling 1-800-EFA-1000 or www.efa.org.
    Web page c by pholt. Last update: 7/14/2006.